NAVANAPHAR Stock Overview
Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Navana Pharmaceuticals PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳48.60 |
| 52 Week High | ৳118.90 |
| 52 Week Low | ৳36.20 |
| Beta | -0.13 |
| 1 Month Change | -5.08% |
| 3 Month Change | -5.26% |
| 1 Year Change | -41.52% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 84.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| NAVANAPHAR | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -0.4% | -0.3% | 0.7% |
| 1Y | -41.5% | -25.8% | -21.2% |
Return vs Industry: NAVANAPHAR underperformed the BD Pharmaceuticals industry which returned -26.1% over the past year.
Return vs Market: NAVANAPHAR underperformed the BD Market which returned -21.2% over the past year.
Price Volatility
| NAVANAPHAR volatility | |
|---|---|
| NAVANAPHAR Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in BD Market | 8.7% |
| 10% least volatile stocks in BD Market | 3.4% |
Stable Share Price: NAVANAPHAR's share price has been volatile over the past 3 months compared to the BD market.
Volatility Over Time: NAVANAPHAR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 4,408 | Md. Shafiq | www.navanapharma.com |
Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. The company was incorporated in 1986 and is based in Dhaka, Bangladesh.
Navana Pharmaceuticals PLC Fundamentals Summary
| NAVANAPHAR fundamental statistics | |
|---|---|
| Market cap | ৳5.22b |
| Earnings (TTM) | ৳420.22m |
| Revenue (TTM) | ৳7.40b |
12.4x
P/E Ratio0.7x
P/S RatioIs NAVANAPHAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NAVANAPHAR income statement (TTM) | |
|---|---|
| Revenue | ৳7.40b |
| Cost of Revenue | ৳4.03b |
| Gross Profit | ৳3.37b |
| Other Expenses | ৳2.95b |
| Earnings | ৳420.22m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.91 |
| Gross Margin | 45.54% |
| Net Profit Margin | 5.68% |
| Debt/Equity Ratio | 116.9% |
How did NAVANAPHAR perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield36%
Payout RatioDoes NAVANAPHAR pay a reliable dividends?
See NAVANAPHAR dividend history and benchmarks| Navana Pharmaceuticals dividend dates | |
|---|---|
| Ex Dividend Date | Nov 20 2024 |
| Dividend Pay Date | Jan 30 2025 |
| Days until Ex dividend | 41 days |
| Days until Dividend pay date | 30 days |
Does NAVANAPHAR pay a reliable dividends?
See NAVANAPHAR dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 04:59 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Navana Pharmaceuticals PLC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|